Ubs Asset Management Americas Inc Nuvalent, Inc. Transaction History
Ubs Asset Management Americas Inc
- $277 Billion
- Q1 2024
A detailed history of Ubs Asset Management Americas Inc transactions in Nuvalent, Inc. stock. As of the latest transaction made, Ubs Asset Management Americas Inc holds 98,123 shares of NUVL stock, worth $7.07 Million. This represents 0.0% of its overall portfolio holdings.
Number of Shares
98,123
Previous 24,823
295.29%
Holding current value
$7.07 Million
Previous $1.83 Million
303.5%
% of portfolio
0.0%
Previous 0.0%
Shares
5 transactions
Others Institutions Holding NUVL
# of Institutions
183Shares Held
54.4MCall Options Held
838KPut Options Held
116K-
Deerfield Management Company, L.P. (Series C) New York, NY20MShares$1.44 Billion31.01% of portfolio
-
Paradigm Biocapital Advisors LP New York, NY4.18MShares$301 Million11.77% of portfolio
-
Vanguard Group Inc Valley Forge, PA3.41MShares$246 Million0.01% of portfolio
-
Perceptive Advisors LLC New York, NY2.78MShares$201 Million4.39% of portfolio
-
Black Rock Inc. New York, NY2.71MShares$195 Million0.0% of portfolio
About Nuvalent, Inc.
- Ticker NUVL
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 42,977,800
- Market Cap $3.1B
- Description
- Nuvalent, Inc., a clinical stage biopharmaceutical company, develops therapies for patients with cancer. Its lead product candidates are NVL-520, a brain-penetrant ROS1-selective inhibitor to inhibit ROS1 fusions that express the normal ROS1 kinase domain without any drug-resistant mutations and remain active in the presence of mutations conferr...